Format

Send to

Choose Destination
Br J Clin Pharmacol. 2010 Sep;70(3):342-5. doi: 10.1111/j.1365-2125.2009.03569.x.

Drugs, money and society (Part II).

Author information

1
Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK. twalley@liv.ac.uk

Abstract

Pharmacoeconomics started as marketing but has developed into a valuable tool in the fuller assessment of drug therapies. Its principles are now widely accepted, and many countries have government-funded agencies with responsibility for its application, most notably the National Institute for Health and Clinical Excellence in England. Many clinical pharmacologists are active in this area, and the discipline itself is part of the clinical pharmacology trainees' curriculum. Further developments will include value-based pricing and its use in cost sharing arrangements between health service and manufacturers.

PMID:
20716232
PMCID:
PMC2949904
DOI:
10.1111/j.1365-2125.2009.03569.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center